logo
  

Advanced Medical Solutions H1 Trading In Line With Board's View

Advanced Medical Solutions Group plc (AMS.L) said that its trading in the first half of 2022 continues to be strong and in line with the Board's expectations as healthcare markets return to normal. Group revenues for the period are expected to be approximately 58 million pounds.

Both Business Units performed well during the first half and the Board remains confident that the Group is on track to meet market expectations for the full year.

The Group expects to announce its interim results for the six-month period ended 30 June 2022 on Wednesday 14th September 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Activity in the U.S. manufacturing sector slowed by more than expected in the month of September but still saw continued growth, according to a report released by the Institute for Supply Management on Monday. Stocks have moved sharply higher in morning trading on Monday, regaining ground following a dismal September. The major averages have all shown substantial moves to the upside. Swedish geneticist Svante Paabo has won this year's Nobel Prize in Physiology/Medicine for his discoveries concerning the genomes of extinct hominins and human evolution. Through his pioneering research, Svante Pääbo accomplished something seemingly impossible: sequencing the genome of the Neanderthal, an extinct relative of present-day humans. He also made the sensational discovery of a previous
RELATED NEWS
Follow RTT